UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 292

Sortiert nach

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia

Gynecologic oncology, 2012-04, Vol.125 (1), p.136-140

2012

Volltextzugriff (PDF)

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples in a phase I study of mirvetuximab soravtansine, a FRα-targeting antibody-drug conjugate (ADC), in relapsed epithelial ovarian cancer patients

Gynecologic oncology, 2017-06, Vol.145, p.34-34

2017

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for advanced ovarian, fallopian tube and peritoneal cancer: An ancillary study of GOG 262

Gynecologic oncology, 2017-06, Vol.145, p.68-68

2017

Volltextzugriff (PDF)

A phase I study of veliparib (ABT-888) in combination with carboplatin and gemcitabine in subjects with advanced ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.54-54

2014

Volltextzugriff (PDF)

Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262

Gynecologic oncology, 2014-06, Vol.133, p.58-58

2014

Volltextzugriff (PDF)

Electrochemical hydrogen sensor for safety monitoring

Solid state ionics, 2004-11, Vol.175 (1), p.527-530

2004

Volltextzugriff (PDF)

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

The New England journal of medicine, 2016-02, Vol.374 (8), p.738-748

2016

Volltextzugriff (PDF)

Utilization of the emergency department by gynecologic oncology patients: High rates and high needs in a medically vulnerable population

Gynecologic oncology, 2020-10, Vol.159, p.73-73

2020

Volltextzugriff (PDF)

741MO Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion

Annals of oncology, 2023-10, Vol.34, p.S508-S508

2023

Volltextzugriff (PDF)

Gynecologic cancer patients’ awareness of palliative care

Gynecologic oncology, 2020-10, Vol.159, p.313-314

2020

Volltextzugriff (PDF)

Mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin and bevacizumab: Initial results from a phase Ib study in patients (pts) with ovarian cancer

Annals of oncology, 2019-10, Vol.30, p.v419-v420

2019

Volltextzugriff (PDF)

1028P - Mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin and bevacizumab: Initial results from a phase Ib study in patients (pts) with ovarian cancer

Annals of oncology, 2019-10, Vol.30, p.v419-v420

2019

Volltextzugriff (PDF)

Initial safety and activity findings from a phase IB escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα-targeting antibody-drug conjugate (ADC), with pembrolizumab in platinum-resistant epithelial ovarian cancer (EOC) patients

Gynecologic oncology, 2018-06, Vol.149, p.38-38

2018

Volltextzugriff (PDF)

Opportunities for improved Lynch syndrome tumor screening in endometrial cancer patients surgically treated at an NCI-designated comprehensive cancer center

Gynecologic oncology, 2018-06, Vol.149, p.208-208

2018

Volltextzugriff (PDF)

Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), with pembrolizumab in platinum-resistant ovarian cancer (PROC): Initial results of an expansion cohort from FORWARD II, a phase Ib study

Annals of oncology, 2018-10, Vol.29, p.viii339-viii339

2018

Volltextzugriff (PDF)

1231 A phase I study of axitinib (AG-013736) combined with paclitaxel/carboplatin (P/C), gemcitabine/cisplatin (Gem/Cis) or pemetrexed/cisplatin (Pem/Cis) in patients (pts) with solid tumours, including advanced non-small cell lung cancer (NSCLC)

European journal of cancer supplements, 2009, Vol.7 (2), p.130-130

2009

Volltextzugriff (PDF)

Generalized Michaelis-Menten rate law with time-varying molecular concentrations

PLoS computational biology, 2023-12, Vol.19 (12), p.e1011711-e1011711

2023

Volltextzugriff (PDF)

Experimental and simulated ultrasonic characterization of complex damage in fused silica

IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 2002-02, Vol.49 (2), p.255-265

2002

Volltextzugriff (PDF)

Large-scale metabolic interaction network of the mouse and human gut microbiota

Scientific data, 2020-06, Vol.7 (1), p.204-204, Article 204

2020

Volltextzugriff (PDF)

Evaluation of Ultrasonically Determined Elasticity-Porosity Relations in Zinc Oxide

Journal of the American Ceramic Society, 1996-05, Vol.79 (5), p.1281-1289

1996

Volltextzugriff (PDF)

Chapter 8 - Ovarian Cancer: New Targets and Future Directions

Translational Advances in Gynecologic Cancers, 2017, p.151-170

2017

Volltextzugriff (PDF)

Correlation between Surface Area Reduction and Ultrasonic Velocity in Sintered Zinc Oxide Powders

Journal of the American Ceramic Society, 1997-04, Vol.80 (4), p.839-846

1997

Volltextzugriff (PDF)

Effect of particle size distribution upon specific surface area and ultrasonic velocity in sintered ceramic powders

Materials science & engineering. A, Structural materials : properties, microstructure and processing, 1998-05, Vol.246 (1), p.151-160

1998

Volltextzugriff (PDF)

A dielectric mixing law for porous ceramics based on fractal boundaries

Journal of applied physics, 1996-10, Vol.80 (7), p.3992-4000

1996

Volltextzugriff (PDF)

Ultrasonic determination of elastic moduli in cement during hydrostatic loading to 1 GPa

Materials science & engineering. A, Structural materials : properties, microstructure and processing, 2000-02, Vol.279 (1), p.87-94

2000

Volltextzugriff (PDF)

1 – 25 von 292

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(269)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(210)
Life Sciences & Biomedicine
(137)
Humans
(81)
Physical Sciences
(54)
Male
(43)
Female
(42)
Technology
(39)
Animals
(31)
Biological And Medical Sciences
(30)
Physics
(29)
Chemistry
(28)
Aged
(24)
Adult
(23)
Medical Sciences
(22)
Middle Aged
(21)
Science & Technology - Other Topics
(20)
Materials Science
(18)
Engineering
(17)
Treatment Outcome
(15)
Exact Sciences And Technology
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples in a phase I study of mirvetuximab soravtansine, a FRα-targeting antibody-drug conjugate (ADC), in relapsed epithelial ovarian cancer patients

Neoadjuvant chemotherapy for advanced ovarian, fallopian tube and peritoneal cancer: An ancillary study of GOG 262

A phase I study of veliparib (ABT-888) in combination with carboplatin and gemcitabine in subjects with advanced ovarian cancer

Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262

Electrochemical hydrogen sensor for safety monitoring

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer

Utilization of the emergency department by gynecologic oncology patients: High rates and high needs in a medically vulnerable population

741MO Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion

Gynecologic cancer patients’ awareness of palliative care

Mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin and bevacizumab: Initial results from a phase Ib study in patients (pts) with ovarian cancer

1028P - Mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin and bevacizumab: Initial results from a phase Ib study in patients (pts) with ovarian cancer

Initial safety and activity findings from a phase IB escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα-targeting antibody-drug conjugate (ADC), with pembrolizumab in platinum-resistant epithelial ovarian cancer (EOC) patients

Opportunities for improved Lynch syndrome tumor screening in endometrial cancer patients surgically treated at an NCI-designated comprehensive cancer center

Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), with pembrolizumab in platinum-resistant ovarian cancer (PROC): Initial results of an expansion cohort from FORWARD II, a phase Ib study

1231 A phase I study of axitinib (AG-013736) combined with paclitaxel/carboplatin (P/C), gemcitabine/cisplatin (Gem/Cis) or pemetrexed/cisplatin (Pem/Cis) in patients (pts) with solid tumours, including advanced non-small cell lung cancer (NSCLC)

Generalized Michaelis-Menten rate law with time-varying molecular concentrations

Experimental and simulated ultrasonic characterization of complex damage in fused silica

Large-scale metabolic interaction network of the mouse and human gut microbiota

Evaluation of Ultrasonically Determined Elasticity-Porosity Relations in Zinc Oxide

Chapter 8 - Ovarian Cancer: New Targets and Future Directions

Correlation between Surface Area Reduction and Ultrasonic Velocity in Sintered Zinc Oxide Powders

Effect of particle size distribution upon specific surface area and ultrasonic velocity in sintered ceramic powders

A dielectric mixing law for porous ceramics based on fractal boundaries

Ultrasonic determination of elastic moduli in cement during hydrostatic loading to 1 GPa

Suchergebnisse filtern